Chundsell Medicals Company

Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. The Prostatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Technology: P4 Medicine
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Kista, Stockholms Lan, Sweden
Founded Date: 2007-01-01
Investors Number: 1
Estimated Revenue: $1M to $10M
Last Funding Type: Private Equity

Visit Website
Register and Claim Ownership